Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Future Medicinal Chemistry
|
March 24, 2011
Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry
Soledad Royo Gracia, Katharina Gaus, Norbert Sewald
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 18, 2017
Bike peptides: a ride through the membrane
Júlia García-Pindado, Soledad Royo, Meritxell Teixidó, et al.
Chirality
|
December 19, 2001
First synthesis of the two enantiomers of alpha-methyldiphenylalanine [(alphaMe)Dip] by HPLC resolution
Soledad Royo, Pilar López, Ana I Jiménez, et al.
Organic Letters
|
December 15, 2006
A helical, aromatic, peptide nanotube
Marco Crisma, Claudio Toniolo, Soledad Royo, et al.
Future Medicinal Chemistry
|
September 13, 2013
Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia
Abraham López, Laura Mendieta, Roger Prades, et al.
Amino Acids
|
September 15, 2011
Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1
Jens Conradi, Sylwia Huber, Katharina Gaus, et al.
Journal of the American Chemical Society
|
February 17, 2005
Turn and helical peptide handedness governed exclusively by side-chain chiral centers
Soledad Royo, Wim M De Borggraeve, Cristina Peggion, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 11, 2005
Preferred 3D-structure of peptides rich in a severely conformationally restricted cyclopropane analogue of phenylalanine
Marco Crisma, Wim M De Borggraeve, Cristina Peggion, et al.
Journal of Medicinal Chemistry
|
February 8, 2013
Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis
Markus Nahrwold, Christine Weiß, Tobias Bogner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 18, 2016
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
Roger Prades, Eva Munarriz-Cuezva, Leyre Urigüen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Future Medicinal Chemistry
|
March 24, 2011
Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry
Soledad Royo Gracia, Katharina Gaus, Norbert Sewald
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 18, 2017
Bike peptides: a ride through the membrane
Júlia García-Pindado, Soledad Royo, Meritxell Teixidó, et al.
Chirality
|
December 19, 2001
First synthesis of the two enantiomers of alpha-methyldiphenylalanine [(alphaMe)Dip] by HPLC resolution
Soledad Royo, Pilar López, Ana I Jiménez, et al.
Organic Letters
|
December 15, 2006
A helical, aromatic, peptide nanotube
Marco Crisma, Claudio Toniolo, Soledad Royo, et al.
Future Medicinal Chemistry
|
September 13, 2013
Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia
Abraham López, Laura Mendieta, Roger Prades, et al.
Amino Acids
|
September 15, 2011
Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1
Jens Conradi, Sylwia Huber, Katharina Gaus, et al.
Journal of the American Chemical Society
|
February 17, 2005
Turn and helical peptide handedness governed exclusively by side-chain chiral centers
Soledad Royo, Wim M De Borggraeve, Cristina Peggion, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 11, 2005
Preferred 3D-structure of peptides rich in a severely conformationally restricted cyclopropane analogue of phenylalanine
Marco Crisma, Wim M De Borggraeve, Cristina Peggion, et al.
Journal of Medicinal Chemistry
|
February 8, 2013
Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis
Markus Nahrwold, Christine Weiß, Tobias Bogner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 18, 2016
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
Roger Prades, Eva Munarriz-Cuezva, Leyre Urigüen, et al.
Page
of 1